SEC Form 4 · accession 0001209191-17-050698
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Brett Primiano
Officer — SVP, OPS, BUS DEV, GC & SEC
Period of report
Aug 29, 2017
Accepted (ET)
Aug 30, 2017 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 29, 2017 | S | 2,195 | $10.00 | D | 15,686 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2Includes 2,062 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan.